Alnylam Pharmaceuticals, Inc. (ETR:DUL)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51,080	29,316	21,731	27,358	17,834	12,344
Market Cap Growth	53.51%	34.90%	-20.57%	53.40%	44.47%	7.89%
Enterprise Value	51,122	29,263	21,965	27,663	17,475	11,967
Last Close Price	394.10	-	227.20	227.20	150.30	106.54
PS Ratio	18.67	13.50	13.14	28.18	24.02	30.64
PB Ratio	256.24	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	256.24	452.40	-	-	34.48	14.86
P/FCF Ratio	270.74	-	572.67	-	-	-
P/OCF Ratio	225.42	-	230.62	-	-	-
EV/Sales Ratio	18.50	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	270.96	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.07%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.37%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.